Finance

Lists
6IRA:FRA
IRLAB Therapeutics AB
€0.16
+5.52%
(+0.0086) 1D
Sep 10, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 6IRA...
Open
€0.16
High
€0.16
Low
€0.16
Mkt. cap
282.10M
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.23
52-wk low
€0.10
No. of employees
31
Open
€0.16
High
€0.16
Low
€0.16
Mkt. cap
282.10M
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.23
52-wk low
€0.10
No. of employees
31
About IRLAB Therapeutics AB
CEORichard Godfrey
Employees31
Founded2013
Headquarters-
SectorPharmaceutical industry
Websiteirlab.se
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
18.85M
14.72M
39.36M
6.40M
Cost of goods sold
26.88M
21.38M
18.70M
11.59M
Cost of revenue
26.88M
21.38M
18.70M
11.59M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.39M
12.74M
10.03M
10.79M
Operating expense
9.14M
8.83M
9.93M
11.52M
Total operating expenses
36.02M
30.20M
28.63M
23.11M
Operating income
-17.17M
-15.48M
10.73M
-16.70M
Other non operating income
-1.00K
-
1.00K
1.00K
EBT including unusual items
-20.23M
-23.49M
9.12M
-19.24M
EBT excluding unusual items
-20.23M
-23.49M
9.12M
-19.24M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-1.29M
-4.95M
-1.14M
-296.00K
Net income
-20.23M
-23.49M
9.12M
-19.24M
Net profit margin
-107.36%
-159.55%
23.18%
-300.42%
Earnings per share
-
-
-
-
Interest and investment income
315.00K
423.00K
330.00K
224.00K
Interest expense
-3.38M
-2.06M
-1.94M
-2.76M
Net interest expenses
-3.06M
-1.63M
-1.61M
-2.54M
Depreciation and amortization charges
1.04M
1.04M
1.04M
1.03M
EBITDA
-16.13M
-14.44M
11.77M
-15.68M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps